If light therapy proves to be an effective antidepressant in T2D patients and improves insulin sensitivity, light therapy may be a valuable addition to the currently available treatment options for major depression in T2D patients, assuming that improvements in insulin sensitivity may ultimately lead to improvements in glycaemic control. Here, INS is linked to type 2 diabetes mellitus.